, /PRNewswire/ -- Velico is pleased to announce that Vitalant, the nation's largest independent, nonprofit blood services provider, has joined Velico's Blood Center Education Program (BCEP) to explore the potential integration of spray dried plasma production into its blood center component operations.
Through the BCEP initiative, Vitalant will gain hands on experience with Velico's FrontlineODP™ Spray Dried Plasma System, a cutting-edge technology designed to empower regional blood centers with the capability to produce and distribute spray dried plasma. This innovative solution is aimed at providing life-saving plasma for transfusion at the point of injury, benefiting patients in emergency situations, battlefield environments, hospitals, and other austere settings where traditional blood products are either unavailable or impractical.
Velico's proprietary spray drying process produces a powdered plasma product that is stable at room temperature, easily reconstituted with sterile water, and transfusion ready within approximately 2.5 minutes.
Richard Meehan, President and CEO of Velico Medical, expressed his enthusiasm about the collaboration:"We are thrilled that Vitalant has embraced the BCEP program and joined our mission to reduce preventable deaths from bleeding. FrontlineODP™ (On Demand Plasma) has the potential to be a game-changing, lifesaving solution for emergency medical services (EMS), particularly in underserved rural areas and on the battlefield."
Dave Green, President and CEO of Vitalant, emphasized the alignment of this partnership with Vitalant's mission: "Participating in BCEP aligns perfectly with our commitment to delivering lifesaving blood whenever and wherever it is needed. As a recognized leader in transfusion medicine, we continuously seek advancements that enhance the quality and reach of our blood services."
CAUTION: Investigational device. Limited by Federal (or US) law to investigational use.
The FrontlineODP ™ Spray Dried Plasma System is currently under investigation and has not received FDA approval for any indication.
Program Funded by BARDA. Contract number #75A50121C00059
About Velico:
Velico, is a private US medical technology company, committed to the mission of eliminating preventable death from bleeding. Headquartered in Beverly, Massachusetts, USA. Velico personnel have substantial expertise and experience in transfusion medicine and medical device development. In support of its mission, Velico is developing partnerships with civilian, government and military blood center leadership, trauma surgeons, emergency medical physicians, military medics and first responders worldwide.
For more information visit www.veli.co
About Vitalant:
Vitalant (pronounced Vye-TAL-ent) is the largest independent, nonprofit blood services provider in the U.S., supplying lifesaving blood and transfusion medicine services to approximately 900 hospitals nationwide. Every day, Vitalant requires nearly 5,000 blood, platelet, and plasma donations to support patient care.
For more information or to schedule a donation, visit vitalant.org or call 877-25-VITAL (877-258-4825). Follow Vitalant on Facebook, Twitter, and Instagram.
SOURCE Velico Medical, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
Comments